Concentration-controlled everolimus versus MMF in De Novo heart transplant patients:: Incidence of CMV infection at 12 months post-transplant in a randomized trial

被引：1
|
作者：
Dengler, T. [1 ]
Vigano, M. [2 ]
Magelli, C. [3 ]
Guillemain, R. [4 ]
Varnous, S. [5 ]
Gerosa, G. [6 ]
Poncelet, A. [7 ]
Vanhaecke, J. [8 ]
Li, Y. [9 ]
Gezahegen, Y. [9 ]
机构：
[1] Heidelberg Univ, Heidelberg, Germany
[2] Univ Pavia, IRCCS, Policlin S Matteo, I-27100 Pavia, Italy
[3] Az Osp Bologna, Policlin S Orsola Malpighi, Bologna, Italy
[4] Europeen Georges Pompidou, Paris, France
[5] Hop La Pitie Salpetriere, Paris, France
[6] Univ Padua, Azienda Osped Padova, Padua, Italy
[7] Clin Univ St Luc, Brussels, Belgium
[8] Univ Hosp Gasthuisberg, Louvain, Belgium
[9] Novartis Pharma AG, Basel, Switzerland
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2008年 / 27卷 / 02期
关键词：
D O I：
10.1016/j.healun.2007.11.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16
引用
收藏
页码：S65 / S66
页数：2
相关论文
共 50 条
  • [21] A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients
    Chadban, Steven J.
    Eris, Josette Marie
    Kanellis, John
    Pilmore, Helen
    Lee, Po Chang
    Lim, Soo Kun
    Woodcock, Chad
    Kurstjens, Nicol
    Russ, Graeme
    TRANSPLANT INTERNATIONAL, 2014, 27 (03) : 302 - 311
  • [22] Comparison of Wound Healing Events and Effusions in De Novo Heart Transplant Recipients Treated with Everolimus Versus MMF Based Regimens
    Hirt, S.
    Wang, S.
    Kobashigawa, J.
    Lehmkuhl, H.
    Rinaldi, M.
    Eisen, H. J.
    Torre, G.
    Yonan, N.
    Arizon, J. M.
    Lopez, P.
    Dong, G.
    Panis, C.
    Zuckermann, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 131 - 131
  • [23] Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial
    van Gelder, Tenn
    Silva, Helio Tedesco
    de Fijter, Johan W.
    Budde, Klemens
    Kuypers, Dirk
    Tyden, Gunnar
    Lohmus, Aleksander
    Sommerer, Claudia
    Hartmann, Anders
    Le Meur, Yann
    Oellerich, Michael
    Holt, David W.
    Toenshoff, Burkhard
    Keown, Paul
    Campbell, Scott
    Mamelok, Richard D.
    TRANSPLANTATION, 2008, 86 (08) : 1043 - 1051
  • [24] The Effect of Everolimus vs. Calcineurin Inhibitors on Surgical Complications: The Results of a De Novo Heart Transplant Randomized Controlled Trial (SCHEDULE Trial)
    Rashidi, M.
    Esmaily, S.
    Fiane, A. E.
    Gustafsson, E.
    Eiskjaer, H.
    Radegran, G.
    Dellgren, G.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S132 - S133
  • [25] Reduced Incidence of CMV and BK Virus Infection With Everolimus vs Mycophenolate Based Regimen in De Novo Renal Transplant Recipients
    Shihab, F.
    Shaffer, D.
    Qazi, Y.
    Kaplan, B.
    Vincenti, F.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    Peddi, V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 537 - 537
  • [26] Results of a 12-month, multicenter, randomized trial of everolimus with reduced-exposure cyclosporine versus MMF and standard-exposure cyclosporine in De Novo cardiac transplant recipients
    Lebmkuhl, H.
    Livi, U.
    Arizon, J.
    Vigano, M.
    Magelli, C.
    Boissonnat, P.
    Gerosa, G.
    Musumeci, F.
    Gandjbakhch, I.
    Vanhaecke, J.
    Hexham, J. M.
    Mange, K. C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S65 - S65
  • [27] Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial
    Zuckermann, Andreas
    Wang, Shoei-Shen
    Ross, Heather
    Frigerio, Maria
    Eisen, Howard J.
    Bara, Christoph
    Hoefer, Daniel
    Cotrufo, Maurizio
    Dong, Gaohong
    Junge, Guido
    Keogh, Anne M.
    JOURNAL OF TRANSPLANTATION, 2011, 2011
  • [28] Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Huang, M. A.
    Chapman, W. C.
    Foltys, D.
    Witte, S.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (11) : 3008 - 3020
  • [29] CMV Infections Are Less Frequent in De Novo Heart Transplant Recipients Receiving Immunosuppression with Everolimus Plus Reduced CsA Compared to MMF and Standard CsA
    Kobashigawa, J.
    Ross, H.
    Kfoury, A. G.
    Van Bakel, A.
    Ewald, G.
    Burton, J.
    Andreassen, A.
    Banchs, H. L.
    Segovia, J.
    Lopez, P.
    Cines, M.
    Dong, G.
    Potena, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 131 - 132
  • [30] CMV INFECTIONS ARE LESS FREQUENT IN DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING IMMUNOSUPPRESSION WITH EVEROLIMUS PLUS REDUCED CSA COMPARED TO MMF AND STANDARD CSA
    Schulz, U.
    Kobashigawa, J.
    Bara, C.
    Hirt, S.
    Lehmkuhl, H. B.
    Lopez, P.
    Costard-Jaeckle, A.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 22 - 22
12345